• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON MONARCH II IOL DELIVERY SYSTEM, CARTRIDGE B; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON MONARCH II IOL DELIVERY SYSTEM, CARTRIDGE B; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Catalog Number 8065977758
Device Problems Particulates (1451); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Corneal Edema (1791)
Event Type  Injury  
Event Description
In a journal article, non healthcare professional reported that during a cataract extraction with intraocular lens (iol) implant procedure, the physician noted that it was difficult injecting the lens into the eye with a crunching sound.Upon insertion, a white, granular material was noted immediately on the lens and in the anterior chamber.Attempts to remove this material by irrigation and aspiration were only partially successful.The lens was then cut in half with scissors and removed.Vigorous irrigation and aspiration was used to remove the remaining ophthalmic viscosurgical device (ovd) and the white, granular material from the capsular bag.Some of this material was noted in the clear corneal wound, which could not be removed.Another same model lens was then injected into the bag.Postoperatively, the patient initially developed corneal edema at 1 week.At 1 month postoperatively, the last time the patient was seen, the eye was quiet, the corneal edema had resolved.It was reported that ophthalmic visco surgical precipitation might have occurred in the case reported here under different circumstances, after lens loading into the injector, or immediately after injection of the lens into the eye.Residues from cartridges coating are also a possibility.There are two medical device reports associated with this article.This report is for 1st report out of 2 reports.
 
Manufacturer Narrative
Investigation, including root cause analysis, is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.Ms hickman, l werner, n mamalis, e sung, d goldstein, dt vroman and sk pandey.Intraoperative explanation of two single-piece hydrophobic acrylic intraocular lenses due to surface deposits.Eye (2006) 20, 1054¿1060.The manufacturer internal reference number is: (b)(4).
 
Manufacturer Narrative
Additional information was provided in sections h.6., and h.10.The product was not returned.Complaint history and product history records could not be reviewed because the literature report did not provide a lot number or any identification traceable to the manufacturing documentation.Qualified associated products were indicated.This complaint was opened from a 2005 literature report: intraoperative explantation of two single-piece hydrophobic acrylic intraocular lenses due to surface deposits.Review of the provided photos appear to show deposits on the surface of the lenses.These deposits cover a large surface area of each lens and have the appearance of dried ovd or other solution.The ¿deposits¿ do not appear to be lens damage or related to the cartridge.The report indicated that surface analyses performed on the material observed intraoperatively by the surgeons only demonstrated the presence of elements that may be normal components of different ovd preparations.The report further indicated that ¿hypothetically, although the analyses performed were not conclusive, ovd precipitation might have occurred in the cases reported here under different circumstances, after lens loading into the injector, or immediately after injection of the lens into the eye¿.Investigation has been completed based on current information.Based on our current tracking, there are no adverse trends for this reported complaint.No further action warranted at this time.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MONARCH II IOL DELIVERY SYSTEM, CARTRIDGE B
Type of Device
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key15884921
MDR Text Key304506649
Report Number1119421-2022-02522
Device Sequence Number1
Product Code MSS
UDI-Device Identifier00380659777585
UDI-Public00380659777585
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K001157
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 02/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number8065977758
Device Lot NumberASKU
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/02/2022
Initial Date FDA Received11/30/2022
Supplement Dates Manufacturer Received01/31/2023
Supplement Dates FDA Received02/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ACRYSOF SINGLEPIECE IOL; MONARCH II IOL DELIVERY SYSTEM, INJECTOR; VANNAS SCISSORS; VISCOAT OPHTHALMIC VISCOSURGICAL DEVICE
Patient Outcome(s) Required Intervention; Other;
Patient Age65 YR
Patient SexMale
-
-